Theresia Thiofani, author
Sintesis Senyawa Antara 2-([4-okso-2-morfolin-1-ilmetil)kuinazolin-3- il]amino)benzonitril = Synthesis Of Intermediate Compound 2-([4-oxo-2-morpholin-1-ylmethyl)quinazolin-3- yl]amino)benzonitrile
Fakultas Farmasi Universitas Indonesia, 2020
 UI - Skripsi (Membership)
Kevin Tanuputra, author
Sintesis Senyawa Antara 2-((4-okso-2-(pirolidin-1-ilmetil)kuinazolin-3- il)amino)benzonitril = Synthesis Intermediate Compound of 2- ((4-oxo-2-(pyrrolidine-1-ylmethyl)quinazolin-3-yl)amino)benzonitrile
Fakultas Farmasi Universitas Indonesia, 2020
 UI - Skripsi (Membership)
Laila Fauziah, author
Sintesis Senyawa Antara 2-([4-okso-2-(N,N-dimetilaminometil) kuinazolin-3-il] amino) benzonitril = Synthesis Intermediate Compound of 2-([4-oxo-2-(N,N-dimethylaminomethyl) quinazoline-3-il] amino) benzonitrile
Fakultas Farmasi Universitas Indonesia, 2020
 UI - Skripsi (Membership)
Benson, author
Sintesis senyawa antara2-([4-okso-(2-{N-metilpiperazin-1-il}metil)kuinazolin-3-il]amino)benzonitril = Synthesis of intermediate compounds of2-([2-{N-methylpiperazine-1-yl)}methyl]-4-oxoquinazolin-3-yl}amino}benzonitrile
Fakultas Farmasi Universitas Indonesia, 2020
 UI - Skripsi (Membership)
Muhammad Fajar Dwi Putra, author
Perbandingan NADPH serum dan korelasinya dengan estimasi laju filtrasi glomerulus pada pasien diabetes melitus tipe 2 yang mendapat angiotensin converting enzyme inhibitor dan angiotensin receptor blocker = Comparison of serum NADPH and its correlation with estimated filtration rate in type 2 diabetes mellitus patients who received angiotensin converting enzyme inhibitor and angiotensin receptor blocker
Fakultas Farmasi Universitas Indonesia, 2018
 UI - Skripsi (Membership)
<<   1 2 3   >>